Home / Manufacturing


Pluristem Granted Patent for Foundational Cell Harvesting Technology in South Africa פלוריסטם קיבל פטנט בדרום אפריקה לטכנולוגיה לקציר תאים

Patent Covers Methods for Using Vibration to Harvest Large Yields of Viable Cells Grown With Three-Dimensional Technology HAIFA, Israel, Jan. 6, 2015 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that ...

Read More »

Protalix BioTherapeutics Announces New Strategy for Accelerated Growth פרוטליקס מכריז על אסטרטגיה חדשה לצמיחה מואצת

Protalix Biotherapeutics, a biopharmaceutical company focused on developing recombinant therapeutic proteins expressed through its plant cell-based expression system, is prioritizing pipeline candidates to focus on bio-better products with a clear competitive advantage. Therapeutic areas of focus will include Fabry disease, inflammatory bowel disease, ...

Read More »

Therapix Bio Plans Exclusive License of Anti-CD3 Antibody to Chinese Company תראפיקס ביו מתכנן רישיון בלעדי של נוגדן טיפולי לסין

Therapix Biosciences subsidiary OrImmune Bio has entered into a strategic collaboration with Nanjing BioSciKin Co to discuss an exclusive license to develop, manufacture and commercialize the company’s anti-CD3 antibody in China. As part of the agreement, Nanjing BioSciKin would provide a $300,000 cash ...

Read More »

Teva Pharmaceutical Industries (NYSE:TEVA; TASE:TEVA) Recalls Parkinson’s Disease Medication טבע תעשיות פרמצבטיות מבצעת ריקול בתרופה למחלת פרקינסון

Teva Pharmaceutical Industries Ltd. is issuing a Class II recall of one lot (3,881 bottles) of carbidopa/levodopa 25 mg/100 mg, a generic drug used to treat Parkinson’s disease, due to the potential for “superpotent” tablets. The lot in question was manufactured ...

Read More »